Cargando…
Metformin revert insulin‐induced oxaliplatin resistance by activating mitochondrial apoptosis pathway in human colon cancer HCT116 cells
BACKGROUND: Several studies have suggested that drug resistance in colon cancer patients with diabetes may be associated with long‐term insulin administration, which in turn decreases the survival rate. Metformin is a commonly used drug to treat diabetes but has been recently demonstrated to have a...
Autores principales: | Liu, Chao, Liu, Qianqian, Yan, Aiwen, Chang, Hui, Ding, Yuyin, Tao, Junye, Qiao, Chen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7286444/ https://www.ncbi.nlm.nih.gov/pubmed/32248666 http://dx.doi.org/10.1002/cam4.3029 |
Ejemplares similares
-
Docosahexaenoic Acid Serving As Sensitizing Agents And Gefitinib Resistance Revertants In EGFR Targeting Treatment
por: Ding, Xuansheng, et al.
Publicado: (2019) -
Antichemosensitizing effect of resveratrol in cotreatment with oxaliplatin in HCT116 colon cancer cell
por: Park, Dong-Guk
Publicado: (2014) -
Change in Expression of Survivin Caused by Using Oxaliplatin in HCT116 Colon Cancer Cells
por: Sohn, Won Jun, et al.
Publicado: (2010) -
Bak instead of Bax plays a key role in metformin-induced apoptosis s in HCT116 cells
por: Chen, Hongce, et al.
Publicado: (2021) -
Induction of apoptosis in HCT-116 colon cancer cells by polysaccharide of Larimichthys crocea swim bladder
por: SUO, HUAYI, et al.
Publicado: (2015)